(BUSINESS WIRE)--Immunome, a discovery-stage company with a proprietary native human monoclonal antibody (N-huMAb) discovery platform, has been selected to present at two major emerging life science finance conferences in San Francisco occurring simultaneously with the JP Morgan Healthcare Conference, the world’s largest annual healthcare investor conference.
